← Open Payments lookup

SUSAN COREY: Open Payments

NPI 1144594680 · MILTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,104 in 42 payments from 12 companies in 2025. Trend: 2023 $1,141 · 2024 $1,058 · 2025 $1,104

Food & beverage: $954Honoraria: $150
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$417
Vanda Pharmaceuticals Inc.6$211
H2-Pharma, LLC1$150
Axsome Therapeutics, Inc.5$98
Takeda Pharmaceuticals U.S.A., Inc.3$56
Teva Pharmaceuticals USA, Inc.2$36
ABBVIE INC.2$34
Collegium Pharmaceutical, Inc.2$33
ACADIA Pharmaceuticals Inc1$20
E.R. Squibb & Sons, L.L.C.1$18

Products named: INGREZZA, FANAPT, Auvelity, TRINTELLIX, AUSTEDO XR, VRAYLAR, Jornay PM, NUPLAZID.

Industry payments across DE — which companies pay providers there.